NEW YORK (GenomeWeb News) — Diagnostics developer Med BioGene has received a CA$307,000 ($262,000) grant from the Canadian government to develop biomarkers to help physicians detect and manage cardiovascular disease, the company said Friday.
 
The grant came from the National Research Council Canada Industrial Assistance Program.
 
MBI, based in Vancouver, BC, said it is working with CVD patient samples provided by the University of Ottawa Heart Institute to confirm its biomarkers.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.